Organization

OUR MISSION

“We strive to make prostate cancer diagnosis quicker, more affordable, and less invasive by pairing artificial intelligence technology with ultrasound imaging.”

LEADERSHIP TEAM

Mark Bloemendaal
Chief Executive Officer
Wim Zwart
Algorithm Development Lead
Armand Wemelsfelder
Product Development Lead
Mark Maris
Global Business Development Director
Anna Garrido Utrilla
Clinical Operations Manager

ADVISORY BOARD

Hessel Wijkstra
Clinical Strategic Advisor
Massimo Mischi
Scientific Strategic Advisor
Roland Zegger
Commercial Strategic Advisor

CLINICAL BOARD

Prof. Dr. Hashim Ahmed

Board Member
Prof. Dr. Chris Bangma

Board Member
Prof. Dr. Harrie Beerlage

Chairman
Prof. Dr. Alberto Briganti

Board Member
Prof. Dr. Daniel Eberli

Board Member
Prof. Dr. Jurgen Fütterer

Board Member
Prof. Dr. Peter Pinto

Board Member
Prof. Dr. Hendrick van Poppel

Board Member
Prof. Dr. Georg Salomon

Board Member
Prof. Dr. Jochen Walz

Board Member